This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abbasi F., Reaven G.M.: Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism, 2002; 51: 235–237AbbasiF.ReavenG.M.Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans20025123523710.1053/meta.2002.28970Search in Google Scholar
Bardají A., Vea A.M., Gutierrez C., Ridao C., Richart C., Oliver J.A.: Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 1998; 32: 970–975BardajíA.VeaA.M.GutierrezC.RidaoC.RichartC.OliverJ.A.Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease19983297097510.1016/S0272-6386(98)70071-XSearch in Google Scholar
Chapman A.B., Johnson A.M., Rainguet S., Hossack K., Gabow P., Schrier R.W.: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1997; 8: 1292–1297ChapmanA.B.JohnsonA.M.RainguetS.HossackK.GabowP.SchrierR.W.Left ventricular hypertrophy in autosomal dominant polycystic kidney disease199781292129710.1681/ASN.V8812929259356Search in Google Scholar
Chen H., Watnick T., Hong S.N., Daly B., Li Y., Seliger S.L.: Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients. BMC Nephrol., 2019; 20: 386ChenH.WatnickT.HongS.N.DalyB.LiY.SeligerS.L.Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients20192038610.1186/s12882-019-1555-z681502331653199Search in Google Scholar
de Almeida E.A., de Oliveira E.I., Lopes J.A., Almeida A.G., Lopes M.G., Prata M.M.: Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease. Rev. Port. Cardiol., 2007; 26: 235–243de AlmeidaE.A.de OliveiraE.I.LopesJ.A.AlmeidaA.G.LopesM.G.PrataM.M.Ambulatory blood pressure measurement in young normotensive patients with autosomal dominant polycystic kidney disease200726235243Search in Google Scholar
Ecder T.: Cardiovascular complications in autosomal dominant polycystic kidney disease. Curr. Hypertens. Rev., 2013; 9: 2–11EcderT.Cardiovascular complications in autosomal dominant polycystic kidney disease2013921110.2174/157340211130901000223971638Search in Google Scholar
Ecder T., Edelstein C.L., Chapman A.B., Johnson A.M., Tison L., Gill E.A., Brosnahan G.M., Schrier R.W.: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hyper-tensive patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 1999; 14: 1113–1116EcderT.EdelsteinC.L.ChapmanA.B.JohnsonA.M.TisonL.GillE.A.BrosnahanG.M.SchrierR.W.Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hyper-tensive patients with autosomal dominant polycystic kidney disease1999141113111610.1093/ndt/14.5.111310344347Search in Google Scholar
Ecder T., Schrier R.W.: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. J. Am. Soc. Nephrol., 2001; 12: 194–200EcderT.SchrierR.W.Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects20011219420010.1681/ASN.V12119411134267Search in Google Scholar
Ecder T., Schrier R.W.: Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat. Rev. Nephrol., 2009; 5: 221–228EcderT.SchrierR.W.Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease2009522122810.1038/nrneph.2009.13272031519322187Search in Google Scholar
Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G.: Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature, 2000; 408: 990–994HanaokaK.QianF.BolettaA.BhuniaA.K.PiontekK.TsiokasL.SukhatmeV.P.GugginoW.B.GerminoG.G.Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents200040899099410.1038/3505012811140688Search in Google Scholar
Idrizi A., Barbullushi M., Strakosha A., Kodra S., Thereska N., Zaimi E., Gjyzari A., Petrela E.: The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease. G. Ital. Nefrol., 2007; 24: 595–599IdriziA.BarbullushiM.StrakoshaA.KodraS.ThereskaN.ZaimiE.GjyzariA.PetrelaE.The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease200724595599Search in Google Scholar
Ivy D.D., Shaffer E.M., Johnson A.M., Kimberling W.J., Dobin A., Gabow P.A.: Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1995; 5: 2032–2036IvyD.D.ShafferE.M.JohnsonA.M.KimberlingW.J.DobinA.GabowP.A.Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease199552032203610.1681/ASN.V51220327579051Search in Google Scholar
Joly D., Hummel A., Ruello A., Knebelmann B.: Ciliary function of polycystins: A new model for cystogenesis. Nephrol. Dial. Transplant., 2003; 18: 1689–1692JolyD.HummelA.RuelloA.KnebelmannB.Ciliary function of polycystins: A new model for cystogenesis2003181689169210.1093/ndt/gfg256Search in Google Scholar
Kimberling W.J., Kumar S, Gabow P.A., Kenyon J.B., Connolly C.J., Somlo S.: Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23. Genomics, 1993; 18: 467–472KimberlingW.J.KumarSGabowP.A.KenyonJ.B.ConnollyC.J.SomloS.Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q2319931846747210.1016/S0888-7543(11)80001-7Search in Google Scholar
Lai S., Mastroluca D., Matino S., Panebianco V., Vitarelli A., Capotosto L., Turinese I., Marinelli P., Rossetti M., Galani A., Baiocchi P., D’Angelo A.R., Palange P.: Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease. Kidney Blood Press. Res., 2017; 42: 1290–1302LaiS.MastrolucaD.MatinoS.PanebiancoV.VitarelliA.CapotostoL.TurineseI.MarinelliP.RossettiM.GalaniA.BaiocchiP.D’AngeloA.R.PalangeP.Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease2017421290130210.1159/000486011Search in Google Scholar
Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F. 3rd, Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann. Intern. Med., 2009; 150: 604–612LeveyA.S.StevensL.A.SchmidC.H.ZhangY.L.CastroA.F.3rdFeldmanH.I.KusekJ.W.EggersP.Van LenteF.GreeneT.CoreshJ.CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)A new equation to estimate glomerular filtration rate200915060461210.7326/0003-4819-150-9-200905050-00006Search in Google Scholar
Levy J.C., Matthews D.R., Hermans M.P.: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 1998; 21: 2191–2192LevyJ.C.MatthewsD.R.HermansM.P.Correct homeostasis model assessment (HOMA) evaluation uses the computer program1998212191219210.2337/diacare.21.12.2191Search in Google Scholar
Lumiaho A., Pihlajamäki J., Hartikainen J., Ikäheimo R., Miettinen R., Niemitukia L., Lampainen E., Laakso M.: Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1. Am. J. Kidney Dis., 2003; 41: 1219–1224LumiahoA.PihlajamäkiJ.HartikainenJ.IkäheimoR.MiettinenR.NiemitukiaL.LampainenE.LaaksoM.Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 12003411219122410.1016/S0272-6386(03)00354-8Search in Google Scholar
Mao Z., Xie G., Ong A.C.: Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 2015; 30: 197–203MaoZ.XieG.OngA.C.Metabolic abnormalities in autosomal dominant polycystic kidney disease20153019720310.1093/ndt/gfu04424589722Search in Google Scholar
Martinez-Vea A., Valero F.A., Bardaji A., Gutierrez C., Broch M., Garcia C., Richart C., Oliver J.A.: Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors. Am. J. Nephrol., 2000; 20: 193–200Martinez-VeaA.ValeroF.A.BardajiA.GutierrezC.BrochM.GarciaC.RichartC.OliverJ.A.Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors20002019320010.1159/00001358310878400Search in Google Scholar
Paavola J., Schliffke S., Rossetti S., Kuo I.Y., Yuan S., Sun Z., Harris P.C., Torres V.E., Ehrlich B.E.: Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J. Mol. Cell. Cardiol., 2013; 58: 199–208PaavolaJ.SchliffkeS.RossettiS.KuoI.Y.YuanS.SunZ.HarrisP.C.TorresV.E.EhrlichB.E.Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy20135819920810.1016/j.yjmcc.2013.01.015363614923376035Search in Google Scholar
Perrone R.D., Abebe K.Z., Schrier R.W., Chapman A.B., Torres V.E., Bost J., Kaya D., Miskulin D.C., Steinman T.I., Braun W., Winklhofer F.T., Hogan M.C., Rahbari-Oskoui F., Kelleher C., Masoumi A., et al.: Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol., 2011; 6: 2508–2515PerroneR.D.AbebeK.Z.SchrierR.W.ChapmanA.B.TorresV.E.BostJ.KayaD.MiskulinD.C.SteinmanT.I.BraunW.WinklhoferF.T.HoganM.C.Rahbari-OskouiF.KelleherC.MasoumiA.Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease201162508251510.2215/CJN.04610511318645521903983Search in Google Scholar
Pietrzak-Nowacka M., Safranow K., Bober J., Olszewska M., Birkenfeld B., Nowosiad M., Ciechanowski K.: Calcium-phosphate metabolism parameters and erythrocyte Ca2+ concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch. Med. Sci., 2013; 9: 837–842Pietrzak-NowackaM.SafranowK.BoberJ.OlszewskaM.BirkenfeldB.NowosiadM.CiechanowskiK.Calcium-phosphate metabolism parameters and erythrocyte Ca2+ concentration in autosomal dominant polycystic kidney disease patients with normal renal function2013983784210.5114/aoms.2012.30834Search in Google Scholar
Pietrzak-Nowacka M., Safranow K., Czechowska M., Dutkiewicz G., Kornacewicz-Jach Z., Ciechanowski K.: Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner. Kidney Blood Press. Res., 2012; 36: 301–309Pietrzak-NowackaM.SafranowK.CzechowskaM.DutkiewiczG.Kornacewicz-JachZ.CiechanowskiK.Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner20123630130910.1159/000343419Search in Google Scholar
Ravine D., Gibson R.N., Walker R.G., Sheffield L.J., Kincaid–Smith P., Danks D.M.: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet, 1994; 343: 824–827RavineD.GibsonR.N.WalkerR.G.SheffieldL.J.Kincaid–SmithP.DanksD.M.Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1199434382482710.1016/S0140-6736(94)92026-5Search in Google Scholar
Rostoff P., Gackowski A., Nessler J., Piwowarska W.: Left ventricular hypertrophy – current views on the pathophysiology, association with cardiovascular risk, and therapeutic options. Kardiol. Pol., 2010; 68: 815–823RostoffP.GackowskiA.NesslerJ.PiwowarskaW.Left ventricular hypertrophy – current views on the pathophysiology, association with cardiovascular risk, and therapeutic options201068815823Search in Google Scholar
The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell, 1994; 77: 881–894The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium19947788189410.1016/0092-8674(94)90137-6Search in Google Scholar
Timio M., Monarca C., Pede S., Gentili S., Verdura C., Lolli S.: The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred. Clin. Nephrol., 1992; 37: 245–251TimioM.MonarcaC.PedeS.GentiliS.VerduraC.LolliS.The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred199237245251Search in Google Scholar
Valero F.A., Martinez-Vea A., Bardají A., Gutierrez C., Garcia C., Richart C., Oliver J.A.: Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1999; 10: 1020–1026ValeroF.A.Martinez-VeaA.BardajíA.GutierrezC.GarciaC.RichartC.OliverJ.A.Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease1999101020102610.1681/ASN.V105102010232688Search in Google Scholar
Zeier M., Geberth S., Schmidt K.G., Mandelbaum A., Ritz E.: Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1993; 3: 1451–1457ZeierM.GeberthS.SchmidtK.G.MandelbaumA.RitzE.Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease199331451145710.1681/ASN.V3814518490116Search in Google Scholar